{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:38:50Z","timestamp":1792795130773,"version":"4.5.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL159306"],"award-info":[{"award-number":["R01HL159306"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005189","name":"Leukemia and Lymphoma Society","doi-asserted-by":"publisher","award":["6631-22"],"award-info":[{"award-number":["6631-22"]}],"id":[{"id":"10.13039\/100005189","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008884","name":"Edward P. Evans Foundation","doi-asserted-by":"publisher","award":["138162"],"award-info":[{"award-number":["138162"]}],"id":[{"id":"10.13039\/100008884","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012443","name":"Maryland Stem Cell Research Fund","doi-asserted-by":"publisher","award":["MSCRFL-5650"],"award-info":[{"award-number":["MSCRFL-5650"]}],"id":[{"id":"10.13039\/100012443","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009858","name":"Gabrielle's Angel Foundation for Cancer Research","doi-asserted-by":"publisher","award":["133"],"award-info":[{"award-number":["133"]}],"id":[{"id":"10.13039\/100009858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["RSG-25-1435351-01-ET"],"award-info":[{"award-number":["RSG-25-1435351-01-ET"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"DOI":"10.1038\/s41375-026-03176-x","type":"journal-article","created":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T11:06:31Z","timestamp":1792753591000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Serine auxotrophy is a targetable vulnerability driven by PSAT1 suppression in AML"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-1112-3761","authenticated-orcid":false,"given":"Ilias","family":"Sinanidis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Tsakiroglou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Dubner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Foertsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Gondek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"InYoung","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bogdan","family":"Paun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teodora","family":"Supeanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2126-6778","authenticated-orcid":false,"given":"Liang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Ghiaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1314-0534","authenticated-orcid":false,"given":"W. Brian","family":"Dalton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,23]]},"reference":[{"key":"3176_CR1","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1182\/bloodadvances.2020002981","volume":"5","author":"C Lo Presti","year":"2021","unstructured":"Lo Presti C, Fauvelle F, Jacob M-C, Mondet J, Mossuz P. The metabolic reprogramming in acute myeloid leukemia patients depends on their genotype and is a prognostic marker. Blood Adv. 2021;5:156\u201366.","journal-title":"Blood Adv"},{"key":"3176_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.110278","volume":"38","author":"B-H Choi","year":"2022","unstructured":"Choi B-H, Rawat V, H\u00f6gstr\u00f6m J, Burns PA, Conger KO, Ozgurses ME, et al. Lineage-specific silencing of PSAT1 induces serine auxotrophy and sensitivity to. dietary serine starvation in luminal breast tumors. Cell Rep. 2022;38:110278.","journal-title":"Cell Rep"},{"key":"3176_CR3","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1158\/0008-5472.CAN-24-2471","volume":"85","author":"N Jasani","year":"2025","unstructured":"Jasani N, Xu X, Posorske B, Kim Y, Wang K, Vera O, et al. PHGDH induction by MAPK is essential for melanoma formation and creates an actionable metabolic vulnerability. Cancer Res. 2025;85:314\u201328.","journal-title":"Cancer Res"},{"key":"3176_CR4","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.ccr.2010.01.020","volume":"17","author":"PS Ward","year":"2010","unstructured":"Ward PS, Patel J, Wise DR, Abdel-Wahab O, Bennett BD, Coller HA, et al. The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to. 2-hydroxyglutarate. Cancer Cell. 2010;17:225\u201334.","journal-title":"Cancer Cell"},{"key":"3176_CR5","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.ccr.2010.11.015","volume":"18","author":"ME Figueroa","year":"2010","unstructured":"Figueroa ME, Abdel-Wahab O, Lu C, Ward PS, Patel J, Shih A, et al. Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. Cancer Cell. 2010;18:553\u201367.","journal-title":"Cancer Cell"},{"key":"3176_CR6","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1056\/NEJMoa1716984","volume":"378","author":"CD DiNardo","year":"2018","unstructured":"DiNardo CD, Stein EM, de Botton S, Roboz GJ, Altman JK, Mims AS, et al. Durable remissions with ivosidenib in IDH1-mutated relapsed or refractory AML. N Engl J Med. 2018;378:2386\u201398.","journal-title":"N Engl J Med"},{"key":"3176_CR7","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1182\/blood-2017-04-779447","volume":"130","author":"MD Amatangelo","year":"2017","unstructured":"Amatangelo MD, Quek L, Shih A, Stein EM, Roshal M, David MD, et al. Enasidenib induces acute myeloid leukemia cell differentiation to. promote clinical response. Blood. 2017;130:732\u201341.","journal-title":"Blood"},{"key":"3176_CR8","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41568-021-00378-6","volume":"21","author":"I Mart\u00ednez-Reyes","year":"2021","unstructured":"Mart\u00ednez-Reyes I, Chandel NS. Cancer metabolism: looking forward. Nat Rev Cancer. 2021;21:669\u201380.","journal-title":"Nat Rev Cancer"},{"key":"3176_CR9","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1182\/blood.2022018092","volume":"141","author":"SK Mishra","year":"2023","unstructured":"Mishra SK, Millman SE, Zhang L. Metabolism in acute myeloid leukemia: mechanistic insights and therapeutic targets. Blood. 2023;141:1119\u201335.","journal-title":"Blood"},{"key":"3176_CR10","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1038\/bjc.2017.118","volume":"116","author":"AC Newman","year":"2017","unstructured":"Newman AC, Maddocks ODK. One-carbon metabolism in cancer. Br J Cancer. 2017;116:1499\u2013504.","journal-title":"Br J Cancer"},{"key":"3176_CR11","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1038\/ng.890","volume":"43","author":"JW Locasale","year":"2011","unstructured":"Locasale JW, Grassian AR, Melman T, Lyssiotis CA, Mattaini KR, Bass AJ, et al. Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to. oncogenesis. Nat Genet. 2011;43:869\u201374.","journal-title":"Nat Genet"},{"key":"3176_CR12","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nature10350","volume":"476","author":"R Possemato","year":"2011","unstructured":"Possemato. R, Marks KM, Shaul YD, Pacold ME, Kim D, Birsoy K, et al. Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. Nature. 2011;476:346\u201350.","journal-title":"Nature"},{"key":"3176_CR13","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s13046-022-02386-2","volume":"41","author":"L Colyn","year":"2022","unstructured":"Colyn L, Alvarez-Sola G, Latasa MU, Uriarte I, Herranz JM, Arechederra M, et al. New molecular mechanisms in cholangiocarcinoma: signals triggering interleukin-6 production in tumor cells and KRAS co-opted epigenetic mediators driving metabolic reprogramming. J Exp Clin Cancer Res. 2022;41:183.","journal-title":"J Exp Clin Cancer Res"},{"key":"3176_CR14","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1158\/0008-5472.CAN-20-1541","volume":"81","author":"DC Montrose","year":"2021","unstructured":"Montrose DC, Saha S, Foronda M, McNally EM, Chen J, Zhou XK, et al. Exogenous and Endogenous Sources of Serine Contribute to. Colon Cancer Metabolism, Growth, and Resistance to. 5-Fluorouracil. Cancer Res. 2021;81:2275\u201388.","journal-title":"Cancer Res"},{"key":"3176_CR15","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1038\/ng.3421","volume":"47","author":"GM DeNicola","year":"2015","unstructured":"DeNicola GM, Chen P-H, Mullarky E, Sudderth JA, Hu Z, Wu D, et al. NRF2 regulates serine biosynthesis in non-small cell lung cancer. Nat Genet. 2015;47:1475\u201381.","journal-title":"Nat Genet"},{"key":"3176_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42458-1","volume":"14","author":"C Tombari","year":"2023","unstructured":"Tombari C, Zannini A, Bertolio R, Pedretti S, Audano M, Triboli L, et al. Mutant p53 sustains serine-glycine synthesis and essential amino acids intake promoting breast cancer growth. Nat Commun. 2023;14:6777.","journal-title":"Nat Commun"},{"key":"3176_CR17","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s40170-018-0191-6","volume":"6","author":"TJ Humpton","year":"2018","unstructured":"Humpton TJ, Hock AK, Maddocks ODK, Vousden KH. p53-mediated adaptation to. serine starvation is retained by a common tumour-derived mutant. Cancer Metab. 2018;6:18.","journal-title":"Cancer Metab"},{"key":"3176_CR18","doi-asserted-by":"publisher","first-page":"3253","DOI":"10.1172\/JCI132876","volume":"130","author":"J Liu","year":"2020","unstructured":"Liu J, Zhang C, Wu H, Sun X-X, Li Y, Huang S, et al. Parkin ubiquitinates phosphoglycerate dehydrogenase to. suppress serine synthesis and tumor progression. J Clin Invest. 2020;130:3253\u201369.","journal-title":"J Clin Invest"},{"key":"3176_CR19","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1158\/2159-8290.CD-20-0738","volume":"11","author":"S Bjelosevic","year":"2021","unstructured":"Bjelosevic S, Gruber E, Newbold A, Shembrey C, Devlin JR, Hogg SJ, et al. Serine biosynthesis is a metabolic vulnerability in FLT3-ITD\u2013driven acute myeloid leukemia. Cancer Discov. 2021;11:1582\u201399.","journal-title":"Cancer Discov"},{"key":"3176_CR20","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.cmet.2020.12.005","volume":"33","author":"S Jeong","year":"2021","unstructured":"Jeong S, Savino AM, Chirayil R, Barin E, Cheng Y, Park S-M, et al. High fructose drives the serine synthesis pathway in acute myeloid leukemic cells. Cell Metab. 2021;33:145\u2013.e6.","journal-title":"Cell Metab"},{"key":"3176_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-58966-1","volume":"16","author":"F Huang","year":"2025","unstructured":"Huang F, Wang Y, Zhang X, Gao W, Li J, Yang Y, et al. m6A\/IGF2BP3-driven serine biosynthesis fuels AML stemness and metabolic vulnerability. Nat Commun. 2025;16:4214.","journal-title":"Nat Commun"},{"key":"3176_CR22","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1016\/j.cmet.2019.02.015","volume":"29","author":"MR Sullivan","year":"2019","unstructured":"Sullivan MR, Mattaini KR, Dennstedt EA, Nguyen AA, Sivanand S, Reilly MF, et al. Increased serine synthesis provides an advantage for tumors arising in tissues where serine levels are limiting. Cell Metab. 2019;29:1410\u2013.e4.","journal-title":"Cell Metab"},{"key":"3176_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20223-y","volume":"12","author":"M Tajan","year":"2021","unstructured":"Tajan M, Hennequart M, Cheung EC, Zani F, Hock AK, Legrave N, et al. Serine synthesis pathway inhibition cooperates with dietary serine and glycine limitation for cancer therapy. Nat Commun. 2021;12:366.","journal-title":"Nat Commun"},{"key":"3176_CR24","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1016\/j.celrep.2017.05.067","volume":"19","author":"B Zhang","year":"2017","unstructured":"Zhang B, Zheng A, Hydbring P, Ambroise G, Ouchida AT, Goiny M, et al. PHGDH defines a metabolic subtype in lung adenocarcinomas with poor prognosis. Cell Rep. 2017;19:2289\u2013303.","journal-title":"Cell Rep"},{"key":"3176_CR25","doi-asserted-by":"publisher","DOI":"10.1172\/JCI153436","volume":"132","author":"A D\u2019Avola","year":"2022","unstructured":"D\u2019Avola A, Legrave N, Tajan M, Chakravarty P, Shearer RL, King HW, et al. PHGDH is required for germinal center formation and is a therapeutic target in MYC-driven lymphoma. J Clin Invest. 2022;132:e153436.","journal-title":"J Clin Invest"},{"key":"3176_CR26","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/nchembio.2070","volume":"12","author":"ME Pacold","year":"2016","unstructured":"Pacold ME, Brimacombe KR, Chan SH, Rohde JM, Lewis CA, Swier LJYM, et al. A PHGDH inhibitor reveals coordination of serine synthesis and 1-carbon unit fate. Nat Chem Biol. 2016;12:452\u20138.","journal-title":"Nat Chem Biol"},{"key":"3176_CR27","doi-asserted-by":"publisher","first-page":"4708","DOI":"10.1172\/JCI125022","volume":"129","author":"WB Dalton","year":"2019","unstructured":"Dalton WB, Helmenstine E, Walsh N, Gondek LP, Kelkar DS, Read A, et al. Hotspot SF3B1 mutations induce metabolic reprogramming and vulnerability to. serine deprivation. J Clin Invest. 2019;129:4708\u201323.","journal-title":"J Clin Invest"},{"key":"3176_CR28","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.3390\/cancers14092113","volume":"14","author":"R Vivet-Noguer","year":"2022","unstructured":"Vivet-Noguer R, Tarin M, Canbezdi C, Dayot S, Silva L, Houy A, et al. Glycolysis dependency as a hallmark of SF3B1-mutated cells. Cancers (Basel). 2022;14:2113.","journal-title":"Cancers (Basel)"},{"key":"3176_CR29","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abn5135","volume":"15","author":"SA Mian","year":"2023","unstructured":"Mian SA, Philippe C, Maniati E, Protopapa P, Bergot T, Piganeau M, et al. Vitamin B5 and succinyl-CoA improve ineffective erythropoiesis in SF3B1-mutated myelodysplasia. Sci Transl Med. 2023;15:eabn5135.","journal-title":"Sci Transl Med"},{"key":"3176_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26395-5","volume":"12","author":"M Hennequart","year":"2021","unstructured":"Hennequart M, Labuschagne CF, Tajan M, Pilley SE, Cheung EC, Legrave NM, et al. The impact of physiological metabolite levels on serine uptake, synthesis and utilization in cancer cells. Nat Commun. 2021;12:6176.","journal-title":"Nat Commun"},{"key":"3176_CR31","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1038\/s41416-022-01965-6","volume":"127","author":"M Falcone","year":"2022","unstructured":"Falcone M, Uribe AH, Papalazarou V, Newman AC, Athineos D, Stevenson K, et al. Sensitisation of cancer cells to. radiotherapy by serine and glycine starvation. Br J Cancer. 2022;127:1773\u201386.","journal-title":"Br J Cancer"},{"key":"3176_CR32","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/nature11743","volume":"493","author":"ODK Maddocks","year":"2013","unstructured":"Maddocks ODK, Berkers CR, Mason SM, Zheng L, Blyth K, Gottlieb E, et al. Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells. Nature. 2013;493:542\u20136.","journal-title":"Nature"},{"key":"3176_CR33","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/nature22056","volume":"544","author":"ODK Maddocks","year":"2017","unstructured":"Maddocks ODK, Athineos D, Cheung EC, Lee P, Zhang T, van den Broek NJF, et al. Modulating the therapeutic response of tumours to. dietary serine and glycine starvation. Nature. 2017;544:372\u20136.","journal-title":"Nature"},{"key":"3176_CR34","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1016\/j.cmet.2024.10.019","volume":"36","author":"H Tong","year":"2024","unstructured":"Tong H, Jiang Z, Song L, Tan K, Yin X, He C, et al. Dual impacts of serine\/glycine-free diet in enhancing antitumor immunity and promoting evasion via PD-L1 lactylation. Cell Metab. 2024;36:2493\u2013.e9.","journal-title":"Cell Metab"},{"key":"3176_CR35","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/s42255-019-0108-x","volume":"1","author":"FF Diehl","year":"2019","unstructured":"Diehl FF, Lewis CA, Fiske BP, Vander Heiden MG. Cellular redox state constrains serine synthesis and nucleotide production to. impact cell proliferation. Nat Metab. 2019;1:861\u20137.","journal-title":"Nat Metab"},{"key":"3176_CR36","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.cell.2017.03.023","volume":"169","author":"JR Cantor","year":"2017","unstructured":"Cantor JR, Abu-Remaileh M, Kanarek N, Freinkman E, Gao X, Louissaint A, et al. Physiologic medium rewires cellular metabolism and reveals uric acid as an endogenous inhibitor of UMP synthase. Cell. 2017;169:258\u2013.e17.","journal-title":"Cell"},{"key":"3176_CR37","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40170-025-00376-4","volume":"13","author":"H Jie","year":"2025","unstructured":"Jie H, Wei J, Li Z, Yi M, Qian X, Li Y, et al. Serine starvation suppresses the progression of esophageal cancer by regulating the synthesis of purine nucleotides and NADPH. Cancer Metab. 2025;13:10.","journal-title":"Cancer Metab"},{"key":"3176_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109706","volume":"36","author":"X Li","year":"2021","unstructured":"Li X, Gracilla D, Cai L, Zhang M, Yu X, Chen X, et al. ATF3 promotes the serine synthesis pathway and tumor growth under dietary serine restriction. Cell Rep. 2021;36:109706.","journal-title":"Cell Rep"},{"key":"3176_CR39","doi-asserted-by":"publisher","first-page":"3516","DOI":"10.1158\/0008-5472.CAN-21-4074","volume":"82","author":"M-Y Luo","year":"2022","unstructured":"Luo M-Y, Zhou Y, Gu W-M, Wang C, Shen N-X, Dong J-K, et al. Metabolic and nonmetabolic functions of PSAT1 coordinate signaling cascades to. confer EGFR inhibitor resistance and drive progression in lung adenocarcinoma. Cancer Res. 2022;82:3516\u201331.","journal-title":"Cancer Res"},{"key":"3176_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-022-01266-7","volume":"8","author":"J Jiang","year":"2023","unstructured":"Jiang J, Huang C. Targeting PSAT1 to. mitigate metastasis in tumors with p53-72Pro variant. Sig Transduct Target Ther. 2023;8:1\u201314.","journal-title":"Sig Transduct Target Ther"},{"key":"3176_CR41","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/s41586-022-04758-2","volume":"605","author":"M Rossi","year":"2022","unstructured":"Rossi M, Altea-Manzano P, Demicco M, Doglioni G, Bornes L, Fukano M, et al. PHGDH heterogeneity potentiates cancer cell dissemination and metastasis. Nature. 2022;605:747\u201353.","journal-title":"Nature"},{"key":"3176_CR42","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1158\/2159-8290.CD-19-1228","volume":"10","author":"B Ngo","year":"2020","unstructured":"Ngo B, Kim E, Osorio-Vasquez V, Doll S, Bustraan S, Liang RJ, et al. Limited environmental serine and glycine confer brain metastasis sensitivity to. PHGDH inhibition. Cancer Discov. 2020;10:1352\u201373.","journal-title":"Cancer Discov"},{"key":"3176_CR43","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2022111550","volume":"41","author":"Y Shu","year":"2022","unstructured":"Shu Y, Hao Y, Feng J, Liu H, Li S-T, Feng J, et al. Non-canonical phosphoglycerate dehydrogenase activity promotes liver cancer growth via mitochondrial translation and respiratory metabolism. EMBO J. 2022;41:e111550.","journal-title":"EMBO J"},{"key":"3176_CR44","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1038\/s42255-021-00456-x","volume":"3","author":"C Ma","year":"2021","unstructured":"Ma C, Zheng K, Jiang K, Zhao Q, Sha N, Wang W, et al. The alternative activity of nuclear PHGDH contributes to. tumour growth under nutrient stress. Nat Metab. 2021;3:1357\u201371.","journal-title":"Nat Metab"},{"key":"3176_CR45","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/bs.acr.2023.05.001","volume":"160","author":"J Zhang","year":"2023","unstructured":"Zhang J, Ye Z, Morgenstern R, Townsend DM, Tew KD. Microsomal glutathione transferase 1 in cancer and the regulation of ferroptosis. Adv Cancer Res. 2023;160:107\u201332.","journal-title":"Adv Cancer Res"},{"key":"3176_CR46","doi-asserted-by":"publisher","first-page":"3501","DOI":"10.1158\/0008-5472.CAN-23-2804","volume":"83","author":"A Skwarska","year":"2023","unstructured":"Skwarska A, Konopleva M. BCL-xL targeting to. induce apoptosis and to. eliminate chemotherapy-induced senescent tumor cells: from navitoclax to. platelet-sparing BCL-xL PROTACs. Cancer Res. 2023;83:3501\u20133.","journal-title":"Cancer Res"},{"key":"3176_CR47","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1158\/2643-3230.BCD-24-0342","volume":"6","author":"AGX Zeng","year":"2025","unstructured":"Zeng AGX, Iacobucci I, Shah S, Mitchell A, Wong G, Bansal S, et al. Single-cell transcriptional atlas of human hematopoiesis reveals genetic and hierarchy-based determinants of aberrant AML differentiation. Blood Cancer Discov. 2025;6:307\u201324.","journal-title":"Blood Cancer Discov"},{"key":"3176_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-13402-3","volume":"7","author":"K Funakoshi","year":"2017","unstructured":"Funakoshi K, Bagheri M, Zhou M, Suzuki R, Abe H, Akashi H. Highly sensitive and specific Alu-based quantification of human cells among rodent cells. Sci Rep. 2017;7:13202.","journal-title":"Sci Rep"},{"key":"3176_CR49","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1182\/bloodadvances.2019001127","volume":"4","author":"WB Dalton","year":"2020","unstructured":"Dalton WB, Helmenstine E, Pieterse L, Li B, Gocke CD, Donaldson J, et al. The K666N mutation in SF3B1 is associated with increased progression of MDS and distinct RNA splicing. Blood Adv. 2020;4:1192\u20136.","journal-title":"Blood Adv"},{"key":"3176_CR50","doi-asserted-by":"publisher","first-page":"3961","DOI":"10.1182\/bloodadvances.2023011260","volume":"8","author":"IY Choi","year":"2024","unstructured":"Choi IY, Ling JP, Zhang J, Helmenstine E, Walter W, Tsakiroglou P, et al. The E592K variant of SF3B1 creates unique RNA missplicing and associates with high-risk MDS without ring sideroblasts. Blood Adv. 2024;8:3961\u201371.","journal-title":"Blood Adv"},{"key":"3176_CR51","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1182\/blood.2020006868","volume":"136","author":"J Taylor","year":"2020","unstructured":"Taylor J, Mi X, North K, Binder M, Penson A, Lasho T, et al. Single-cell genomics reveals the genetic and molecular bases for escape from mutational epistasis in myeloid neoplasms. Blood. 2020;136:1477\u201386.","journal-title":"Blood"},{"key":"3176_CR52","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/s42255-020-0195-8","volume":"2","author":"A M\u00e9ndez-Lucas","year":"2020","unstructured":"M\u00e9ndez-Lucas A, Lin W, Driscoll PC, Legrave N, Novellasdemunt L, Xie C, et al. Identifying strategies to. target the metabolic flexibility of tumours. Nat Metab. 2020;2:335\u201350.","journal-title":"Nat Metab"},{"key":"3176_CR53","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.18632\/oncotarget.6426","volume":"7","author":"F Polet","year":"2015","unstructured":"Polet F, Corbet C, Pinto. A, Rubio LI, Martherus R, Bol V, et al. Reducing the serine availability complements the inhibition of the glutamine metabolism to. block leukemia cell growth. Oncotarget. 2015;7:1765\u201376.","journal-title":"Oncotarget"},{"key":"3176_CR54","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.cmet.2019.11.012","volume":"31","author":"SE LeBoeuf","year":"2020","unstructured":"LeBoeuf SE, Wu WL, Karakousi TR, Karadal B, Jackson SR, Davidson SM, et al. Activation of oxidative stress response in cancer generates a druggable dependency on exogenous non-essential amino acids. Cell Metab. 2020;31:339\u2013.e4.","journal-title":"Cell Metab"},{"key":"3176_CR55","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abm9427","volume":"8","author":"KM Fujihara","year":"2022","unstructured":"Fujihara KM, Zhang BZ, Jackson TD, Ogunkola MO, Nijagal B, Milne JV, et al. Eprenetapopt triggers ferroptosis, inhibits NFS1 cysteine desulfurase, and synergizes with serine and glycine dietary restriction. Sci Adv. 2022;8:eabm9427.","journal-title":"Sci Adv"},{"key":"3176_CR56","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1038\/s41591-018-0233-1","volume":"24","author":"DA Pollyea","year":"2018","unstructured":"Pollyea DA, Stevens BM, Jones CL, Winters A, Pei S, Minhajuddin M, et al. Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia. Nat Med. 2018;24:1859\u201366.","journal-title":"Nat Med"},{"key":"3176_CR57","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1158\/2159-8290.CD-23-1145","volume":"14","author":"AI Sheth","year":"2024","unstructured":"Sheth AI, Althoff MJ, Tolison H, Engel K, Amaya ML, Krug AE, et al. Targeting acute myeloid leukemia stem cells through perturbation of mitochondrial calcium. Cancer Discov. 2024;14:1922\u201339.","journal-title":"Cancer Discov"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-03176-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-03176-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-03176-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:02:10Z","timestamp":1792792930000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-03176-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,23]]},"references-count":57,"alternative-id":["3176"],"URL":"https:\/\/doi.org\/10.1038\/s41375-026-03176-x","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,23]]},"assertion":[{"value":"16 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"LZ is an employee of Complete Omics Inc. The remaining authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All methods were performed in accordance with the relevant guidelines and regulations. Collection of primary human AML samples was approved by the Johns Hopkins University Institutional Review Board (IRB-1) under the Hematologic Malignancies Cell Bank Protocol (NA_00028682, cell bank identifier J0969). Written informed consent was obtained from all participants who provided these samples. Animal experiments were approved by the Johns Hopkins University Animal Care and Use Committee (ACUC) under protocol MO25M02.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Ethics"}}]}}